PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8 T Cell Killing

English version České info

Virus-specific cytotoxic T cells can eliminate infected cells during acute viral infections, but in chronic infections these cells often become dysfunctional or “exhausted.” The inhibitory receptor PD-1 is involved in the suppression of cytotoxic T cell responses in chronic infections. However, during many acute viral infections cytotoxic T cells up-regulate the PD-1 receptor but initially remain competent in killing virus infected target cells. Here we show that the ligand for PD-1, called PD-L1, can be induced on retrovirus infected cells and that the cells with the highest expression of PD-L1 escaped from cytotoxic T cell killing. Thus, PD-L1high infected target cells accumulated during the course of infection, formed the reservoir of virus persistence, and subsequently mediated a negative feedback on cytotoxic T cells via the PD-1 receptor that ultimately resulted in functional exhaustion of these cells. The current results provide evidence for a novel escape mechanism of viruses from cytotoxic T cell responses and may explain how viral reservoirs are established during chronic infections.

Vyšlo v časopise: PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8 T Cell Killing. PLoS Pathog 11(10): e32767. doi:10.1371/journal.ppat.1005224
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1005224

Souhrn

Zdroje

1. Kantzanou M, Lucas M, Barnes E, Komatsu H, Dusheiko G, Ward S, et al. Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers. Immunol Lett. 2003;85(2):165–71. Epub 2003/01/16. doi: S0165247802002249 [pii]. 12527224.

2. Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci U S A. 1997;94(18):9848–53. Epub 1997/09/02. 9275214; PubMed Central PMCID: PMC23280.

3. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077):682–7. Epub 2005/12/31. doi: nature04444 [pii] doi: 10.1038/nature04444 16382236.

4. Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol. 2007;81(17):9249–58. Epub 2007/06/15. doi: JVI.00409-07 [pii] doi: 10.1128/JVI.00409-07 17567698; PubMed Central PMCID: PMC1951397.

5. Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, Wehbi M, et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. Journal of Virology. 2007;81(6):2545–53. doi: 10.1128/Jvi.02021-06 ISI:000244850800001.

6. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 2009;10(1):29–37. Epub 2008/12/02. doi: ni.1679 [pii] doi: 10.1038/ni.1679 19043418.

7. Dietze KK, Zelinskyy G, Liu J, Kretzmer F, Schimmer S, Dittmer U. Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads. PLoS pathogens. 2013;9(12):e1003798. Epub 2013/12/18. doi: 10.1371/journal.ppat.1003798 24339778; PubMed Central PMCID: PMC3855586.

8. Palmer BE, Neff CP, Lecureux J, Ehler A, Dsouza M, Remling-Mulder L, et al. In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice. Journal of immunology. 2013;190(1):211–9. Epub 2012/12/05. doi: 10.4049/jimmunol.1201108 23209326; PubMed Central PMCID: PMC3529847.

9. Greenough A, Shaheen SO, Shennan A, Seed PT, Poston L. Respiratory outcomes in early childhood following antenatal vitamin C and E supplementation. Thorax. 2010;65(11):998–1003. Epub 2010/10/05. doi: thx.2010.139915 [pii] doi: 10.1136/thx.2010.139915 20889523.

10. Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T, Nolan BE, Longworth S, Berical A, et al. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol. 2008;82(6):3154–60. Epub 2007/12/28. doi: JVI.02474-07 [pii] doi: 10.1128/JVI.02474-07 18160439; PubMed Central PMCID: PMC2258997.

11. Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology. 2008;134(7):1938–49. doi: 10.1053/j.gastro.2008.03.037 ISI:000256686400019.

12. Petrovas C, Price DA, Mattapallil J, Ambrozak DR, Geldmacher C, Cecchinato V, et al. SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood. 2007;110(3):928–36. Epub 2007/04/19. doi: blood-2007-01-069112 [pii] doi: 10.1182/blood-2007-01-069112 17440051; PubMed Central PMCID: PMC1924769.

13. Santosuosso M, Righi E, Hill ED, Leblanc PR, Kodish B, Mylvaganam HN, et al. R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodes. PLoS One. 2011;6(4):e18465. Epub 2011/04/13. doi: 10.1371/journal.pone.0018465 21483689; PubMed Central PMCID: PMC3071731.

14. Zelinskyy G, Myers L, Dietze KK, Gibbert K, Roggendorf M, Liu J, et al. Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol. 2011;187(7):3730–7. Epub 2011/08/30. doi: jimmunol.1101612 [pii] doi: 10.4049/jimmunol.1101612 21873525.

15. Sakthivel P, Gereke M, Bruder D. Therapeutic intervention in cancer and chronic viral infections: antibody mediated manipulation of PD-1/PD-L1 interaction. Rev Recent Clin Trials. 2012;7(1):10–23. Epub 2011/10/26. 22023178.

16. Seko Y, Yagita H, Okumura K, Azuma M, Nagai R. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3. Cardiovasc Res. 2007;75(1):158–67. Epub 2007/04/17. doi: 10.1016/j.cardiores.2007.03.012 17434153.

17. Blackburn SD, Crawford A, Shin H, Polley A, Freeman GJ, Wherry EJ. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. J Virol. 2010;84(4):2078–89. Epub 2009/12/04. doi: JVI.01579-09 [pii] doi: 10.1128/JVI.01579-09 19955307; PubMed Central PMCID: PMC2812396.

18. Lafon M, Megret F, Meuth SG, Simon O, Velandia Romero ML, Lafage M, et al. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. J Immunol. 2008;180(11):7506–15. Epub 2008/05/21. doi: 180/11/7506 [pii]. 18490751.

19. Telcian AG, Laza-Stanca V, Edwards MR, Harker JA, Wang H, Bartlett NW, et al. RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity. The Journal of infectious diseases. 2011;203(1):85–94. Epub 2010/12/15. doi: 10.1093/infdis/jiq020 21148500; PubMed Central PMCID: PMC3086441.

20. Rodriguez-Garcia M, Porichis F, de Jong OG, Levi K, Diefenbach TJ, Lifson JD, et al. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. Journal of leukocyte biology. 2011;89(4):507–15. Epub 2010/11/26. doi: 10.1189/jlb.0610327 21097698; PubMed Central PMCID: PMC3058820.

21. Hasenkrug KJ, Chesebro B. Immunity to retroviral infection: the Friend virus model. P Natl Acad Sci USA. 1997;94(15):7811–6. Epub 1997/07/22. 9223268; PubMed Central PMCID: PMC33712.

22. Zelinskyy G, Robertson SJ, Schimmer S, Messer RJ, Hasenkrug KJ, Dittmer U. CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection. J Virol. 2005;79(16):10619–26. 16051854.

23. Hasenkrug KJ, Brooks DM, Dittmer U. Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice. J Virol. 1998;72(8):6559–64. 9658100.

24. Nowinski RC, Emery S, Ledbetter J. Identification of an FMR cell surface antigen associated with murine leukemia virus-infected cells. J Virol. 1978;26(3):805–12. Epub 1978/06/01. 78990; PubMed Central PMCID: PMC525905.

25. Robertson MN, Miyazawa M, Mori S, Caughey B, Evans LH, Hayes SF, et al. Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J Virol Methods. 1991;34(3):255–71. Epub 1991/10/01. 1744218.

26. Zelinskyy G, Dietze KK, Husecken YP, Schimmer S, Nair S, Werner T, et al. The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood. 2009;114(15):3199–207. Epub 2009/08/13. doi: blood-2009-03-208736 [pii] doi: 10.1182/blood-2009-03-208736 19671923.

27. Zelinskyy G, Kraft AR, Schimmer S, Arndt T, Dittmer U. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection. Eur J Immunol. 2006;36(10):2658–70. 16981182.

28. Li JP, D'Andrea AD, Lodish HF, Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature. 1990;343(6260):762–4. Epub 1990/02/22. doi: 10.1038/343762a0 2154701.

29. Dittmer U, Race B, Hasenkrug KJ. Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus. J Virol. 1999;73(10):8435–40. 10482595.

30. Dong H, Zhu G, Tamada K, Flies DB, van Deursen JM, Chen L. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity. 2004;20(3):327–36. Epub 2004/03/20. 15030776.

31. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677–704. Epub 2008/01/05. doi: 10.1146/annurev.immunol.26.021607.090331 18173375.

32. Gibbert K, Francois S, Sigmund AM, Harper MS, Barrett BS, Kirchning CJ, et al. Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3. Retrovirology. 2014;11(1):126. Epub 2014/12/30. doi: 10.1186/s12977-014-0126-4 25539593; PubMed Central PMCID: PMC4299798.

33. Kane M, Case LK, Wang C, Yurkovetskiy L, Dikiy S, Golovkina TV. Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry. Immunity. 2011;35(1):135–45. Epub 2011/07/05. doi: 10.1016/j.immuni.2011.05.011 21723157; PubMed Central PMCID: PMC3519935.

34. Gerlach N, Schimmer S, Weiss S, Kalinke U, Dittmer U. Effects of type I interferons on Friend retrovirus infection. Journal of virology. 2006;80(7):3438–44. Epub 2006/03/16. doi: 10.1128/JVI.80.7.3438–3444.2006 16537611; PubMed Central PMCID: PMC1440373.

35. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev. 2010;236:219–42. Epub 2010/07/20. doi: IMR923 [pii] doi: 10.1111/j.1600-065X.2010.00923.x 20636820; PubMed Central PMCID: PMC2919275.

36. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264(5167):1918–21. Epub 1994/06/24. 8009221.

37. Trabattoni D, Saresella M, Biasin M, Boasso A, Piacentini L, Ferrante P, et al. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood. 2003;101(7):2514–20. Epub 2002/12/07. doi: 10.1182/blood-2002-10-3065 12468426.

38. Schepers K, Toebes M, Sotthewes G, Vyth-Dreese FA, Dellemijn TA, Melief CJ, et al. Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas. J Immunol. 2002;169(6):3191–9. 12218137.

39. Chen W, Qin H, Chesebro B, Cheever MA. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J Virol. 1996;70(11):7773–82. 8892898.

40. Zelinskyy G, Balkow S, Schimmer S, Werner T, Simon MM, Dittmer U. The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control. J Virol. 2007;81(21):11881–90. 17728236.

41. Ohlen C, Kalos M, Cheng LE, Shur AC, Hong DJ, Carson BD, et al. CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J Exp Med. 2002;195(11):1407–18. Epub 2002/06/05. 12045239.

42. Wherry EJ. T cell exhaustion. Nature immunology. 2011;12(6):492–9. Epub 2011/07/09. 21739672.

43. Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, Missale G, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol. 2006;80(22):11398–403. Epub 2006/09/08. doi: 10.1128/JVI.01177-06 16956940; PubMed Central PMCID: PMC1642188.

44. Rutigliano JA, Sharma S, Morris MY, Oguin TH 3rd, McClaren JL, Doherty PC, et al. Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells. J Virol. 2014;88(3):1636–51. Epub 2013/11/22. doi: 10.1128/JVI.02851-13 24257598; PubMed Central PMCID: PMC3911576.

45. Greenough TC, Campellone SC, Brody R, Jain S, Sanchez-Merino V, Somasundaran M, et al. Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage. PloS one. 2010;5(9):e12926. Epub 2010/10/05. doi: 10.1371/journal.pone.0012926 20886079; PubMed Central PMCID: PMC2944873.

46. Takamura S, Tsuji-Kawahara S, Yagita H, Akiba H, Sakamoto M, Chikaishi T, et al. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors. J Immunol. 2010;184(9):4696–707. Epub 2010/03/31. doi: jimmunol.0903478 [pii] doi: 10.4049/jimmunol.0903478 20351188.

47. Zinselmeyer BH, Heydari S, Sacristan C, Nayak D, Cammer M, Herz J, et al. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. The Journal of experimental medicine. 2013;210(4):757–74. Epub 2013/03/27. doi: 10.1084/jem.20121416 23530125; PubMed Central PMCID: PMC3620347.

48. Frebel H, Nindl V, Schuepbach RA, Braunschweiler T, Richter K, Vogel J, et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. The Journal of experimental medicine. 2012;209(13):2485–99. Epub 2012/12/12. doi: 10.1084/jem.20121015 23230000; PubMed Central PMCID: PMC3526355.

49. Penaloza-MacMaster P, Kamphorst AO, Wieland A, Araki K, Iyer SS, West EE, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. The Journal of experimental medicine. 2014;211(9):1905–18. Epub 2014/08/13. doi: 10.1084/jem.20132577 25113973.

50. Gerlach N, Gibbert K, Alter C, Nair S, Zelinskyy G, James CM, et al. Anti-retroviral effects of type I IFN subtypes in vivo. European journal of immunology. 2009;39(1):136–46. Epub 2009/01/09. doi: 10.1002/eji.200838311 19130550.

51. Planes R, BenMohamed L, Leghmari K, Delobel P, Izopet J, Bahraoui E. HIV-1 Tat Protein Induces PD-L1 (B7-H1) Expression on Dendritic Cells through Tumor Necrosis Factor Alpha- and Toll-Like Receptor 4-Mediated Mechanisms. J Virol. 2014;88(12):6672–89. Epub 2014/04/04. doi: 10.1128/JVI.00825-14 24696476; PubMed Central PMCID: PMC4054384.

52. Benedict CA, Loewendorf A, Garcia Z, Blazar BR, Janssen EM. Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. Journal of immunology. 2008;180(7):4836–47. Epub 2008/03/21. 18354207; PubMed Central PMCID: PMC2637915.

53. McNally B, Ye F, Willette M, Flano E. Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection. J Virol. 2013;87(23):12916–24. Epub 2013/09/27. doi: 10.1128/JVI.02423-13 24067957; PubMed Central PMCID: PMC3838157.

54. Jin YH, Hou W, Kang HS, Koh CS, Kim BS. The role of interleukin-6 in the expression of PD-1 and PDL-1 on central nervous system cells following infection with Theiler's murine encephalomyelitis virus. J Virol. 2013;87(21):11538–51. Epub 2013/08/24. doi: 10.1128/JVI.01967-13 23966393; PubMed Central PMCID: PMC3807328.

55. Heinecke L, Proud D, Sanders S, Schleimer RP, Kim J. Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies. J Allergy Clin Immunol. 2008;121(5):1155–60. Epub 2008/04/02. doi: 10.1016/j.jaci.2008.02.009 18378285; PubMed Central PMCID: PMC2810151.

56. Driessens G, Kline J, Gajewski TF. Costimulatory and coinhibitory receptors in anti-tumor immunity. Immunological reviews. 2009;229(1):126–44. Epub 2009/05/12. doi: 10.1111/j.1600-065X.2009.00771.x 19426219; PubMed Central PMCID: PMC3278040.

57. Spranger S, Spaapen RM, Zha Y, Williams J, Meng Y, Ha TT, et al. Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells. Sci Transl Med. 2013;5(200):200ra116. Epub 2013/08/30. doi: 10.1126/scitranslmed.3006504 23986400; PubMed Central PMCID: PMC4136707.

58. Robertson SJ, Ammann CG, Messer RJ, Carmody AB, Myers L, Dittmer U, et al. Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J Virol. 2008;82(1):408–18. Epub 2007/10/26. doi: JVI.01413-07 [pii] doi: 10.1128/JVI.01413-07 17959678.

59. Lilly F, Steeves RA. B-tropic Friend virus: a host-range pseudotype of spleen focus-forming virus (SFFV). Virology. 1973;55(2):363–70. 4742777.

60. D'Souza M, Fontenot AP, Mack DG, Lozupone C, Dillon S, Meditz A, et al. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. Journal of immunology. 2007;179(3):1979–87. Epub 2007/07/21. 17641065.

61. Barber DL, Wherry EJ, Ahmed R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol. 2003;171(1):27–31. Epub 2003/06/21. 12816979.

62. Cobbold SP, Waldmann H. Therapeutic potential of monovalent monoclonal antibodies. Nature. 1984;308(5958):460–2. 6608694.

63. Robertson SJ, Messer RJ, Carmody AB, Hasenkrug KJ. In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells. J Immunol. 2006;176(6):3342–9. Epub 2006/03/07. doi: 176/6/3342 [pii]. 16517701.